Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer
Clinical trial NCT06429904 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06429904
- Sponsor
- Peking Union Medical College Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2027-05-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.